| Financial Year |
March 31 2023 |
| Monetary Funds |
2,769,284,974.05 |
| Held-for-trading Financial Assets |
120,354,900.00 |
| Notes Receivable |
6,902,000.00 |
| Accounts Receivable |
2,851,362,463.33 |
| Advances to Suppliers |
403,076,432.56 |
| Other Receivables |
161,190,646.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,294,695.17 |
| Inventories |
1,928,036,709.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
232,765,409.76 |
| Other Current Assets |
104,276,539.37 |
| Total Current Assets |
9,051,223,408.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
87,953,749.38 |
| Long-term Equity Investment |
491,359,029.67 |
| Investment Properties |
146,869,938.34 |
| Fixed Assetes |
1,435,301,739.18 |
| Under-construction Projects |
234,681,264.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
592,964,693.56 |
| R&D expenses |
-- |
| Goodwill |
11,589,632.89 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
154,035,477.58 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,172,758,588.13 |
| Total Assets |
12,223,981,997.07 |
| Short-Term Loans |
710,485,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,064,648,089.23 |
| Accounts Payable |
2,114,803,777.64 |
| Accounts Received In Advance |
15,229.00 |
| Employee Compensation Payable |
162,171,263.15 |
| Taxes Payable |
42,070,155.37 |
| Interest Payable |
-- |
| Dividend Payable |
393,570.00 |
| Other payables |
192,484,172.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
8,127,849.52 |
| Sub-Total of Current Liabilities |
6,557,528,622.46 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,198,178.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
45,246,409.61 |
| Deferred Income Tax Liabilities |
25,369,420.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
311,799,549.36 |
| Total Liabilities |
6,869,328,171.82 |
| Paid-In Capital(Or Share Stock) |
1,501,253,212.00 |
| Capital Surplus |
1,541,019,831.13 |
| Surplus Reserve |
415,806,208.86 |
| LESS:Treasury Stock |
43,005,600.00 |
| Undistributed Profits |
1,687,590,742.54 |
| Minority Stockholder's Interest |
288,940,473.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,065,713,352.18 |
| Owner's Equity（Stockholder's Equity） |
5,354,653,825.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,223,981,997.07 |
